COMPANY INTELLIGENCE PROFILE
Ideawise Technologies Private Limited
Operates as "Lifechart" / "Lifechart Ayurveda" — an Ayurveda-based digital wellness and healthtech platform founded in 2021-2022 by Mukul Shah (CEO), Mansi Shah/Sharma (Chief Business Officer) and K Sandeep (CTO).
Business Overview
Operates as "Lifechart" / "Lifechart Ayurveda" — an Ayurveda-based digital wellness and healthtech platform founded in 2021-2022 by Mukul Shah (CEO), Mansi Shah/Sharma (Chief Business Officer) and K Sandeep (CTO). Lifechart began as an online consultation platform connecting patients to Ayurvedic doctors for chronic conditions (stress, hypertension, sleep disorders, gut issues) and sells herbal syrups/teas D2C via lifechartayurveda.in (Shopify storefront). In 2024 it launched "Guttify," India's first diagnosis-led gut-health brand combining at-home diagnostics (pH-based saliva acidity test, planned Rs 99 kits) with Ayurveda-backed products, targeting India's ~$18B gut-wellness market. DPIIT-recognised startup. Sources: StartupTalky, YourStory, Entrackr, eHealth Magazine, TheCompanyCheck, Outlook India.
Sector & Classification
Sector classified variously as "Computer and related activities" (Tofler), "Internet and Online Healthcare Services" (TheCompanyCheck), and "Professional, scientific and technical activities" (TheCompanyCheck principal activity) — sources disagree on NIC bucket; operationally the company runs healthtech/D2C wellness brands
Directors & Key Management
Directors — source notes
Mukul Shah (DIN 08627198, per Tofler) — Founder/CEO, appointed per Tofler ~4 yrs tenure / TheCompanyCheck lists appointment 10 May 2022. Mansi Shah (DIN 09220482, per Tofler; referred to as "Mansi Sharma" in some press, Chief Business Officer) — appointed 29 June 2021 per TheCompanyCheck. DINs sourced only from Tofler (single source, not cross-confirmed by a second registry site) — treat DINs as partial confidence. Both directors consistently reported by Tofler, TheCompanyCheck and InstaFinancials.
GST Registrations
Primary GSTIN: 07AAGCI2036R1Z7 (Masters India) — state code 07 = Delhi, consistent with registered office; registered ~7 Sept 2021; status Active; Regular taxpayer; PAN embedded = AAGCI2036R. Only one GSTIN identified (Delhi); no evidence of multi-state registrations found. Single-source confirmation (Masters India only) — partial.
Financials
FY2025 (year ended 31 Mar 2025): Revenue ~Rs 1.28 Cr, reported down ~2% YoY (TheCompanyCheck); EBITDA/PAT figures locked behind paywall on both Tofler and TheCompanyCheck. Tofler additionally reports (as of Mar 2025) Net Profit Margin 7.03%, Return on Equity 7.53%, Debt-to-Equity 0.18 — implying a small positive PAT (~Rs 9 lakh order of magnitude if margin applies to the ~Rs1.28Cr revenue, not independently confirmed). Standalone vs consolidated basis not stated by either source. Filed Annual Returns/Financial Statements up to 31 Mar 2024 per one InstaFinancials-derived summary. Overall: partial, single-source per data point, no full P&L available without paid subscription.
Funding History
Two rounds reported: (1) Oct 2024 seed round, ~$500K, led by Prajay Advisors (Unichem Laboratories founders' family office, $250K) with Agility Ventures, Expert Dojo, Sunn91 Ventures, government seed schemes, and angels Nitish Mittersain (Nazara Technologies), Ahana Gautam (Open Secret), Sarath Sura, Marwari Angels (Entrackr, BioSpectrum India). (2) May 2025 extended seed round, $360K, co-led by Prajay Advisors and new investor Unichem Labs, same angel base (Entrackr, eHealth Magazine, BW Disrupt, Indian Startup Times). Cumulative funding reported as "over $1 million." Multiple consistent trade-press sources (Entrackr, eHealth Magazine, BioSpectrum India, BW Disrupt) — confirmed for round existence/amounts; no valuation disclosed.
Loans & Charges
None registered — TheCompanyCheck explicitly states "Charges: None registered." No other source contradicts this.
Credit Ratings
Not obtained — no CRISIL/ICRA/CARE rating found for this company; expected for a small pre-Series-A startup with no registered charges/borrowings requiring a bank rating.
Legal & Compliance
None found — no Indian Kanoon case records located for this entity or its directors under this name/CIN.
Competitive Landscape
India gut-health / microbiome-wellness space: The Good Bug, CosMix Wellness, Veera Health, BugSpeaks (microbiome-based nutraceuticals/personalised probiotics), Leucine Rich Bio, Peping (all early-stage/seed-scale, similar to Guttify). Broader Ayurveda-wellness D2C peers for the Lifechart consultation+products model: Kapiva, Baidyanath, Dabur's digital Ayurveda initiatives, Patanjali (large/legacy scale, much bigger than Ideawise). Sources: YourStory (gut-health-startups trend piece), Outlook India, general market knowledge — named peers are seed/early-stage scale except Dabur/Patanjali which are large legacy FMCG players.
Frequently Asked Questions
What does Ideawise Technologies Private Limited do?
Operates as "Lifechart" / "Lifechart Ayurveda" — an Ayurveda-based digital wellness and healthtech platform founded in 2021-2022 by Mukul Shah (CEO), Mansi Shah/Sharma (Chief Business Officer) and K Sandeep (CTO).
What is the CIN of Ideawise Technologies Private Limited?
Ideawise Technologies Private Limited's Corporate Identification Number (CIN) is U72900DL2021PTC382934.
When was Ideawise Technologies Private Limited incorporated?
Ideawise Technologies Private Limited was incorporated on 29 June 2021 (Tofler, TheCompanyCheck, InstaFinancials — consistent) and is registered with RoC-Delhi.
Who are the directors of Ideawise Technologies Private Limited?
Directors on record include Mukul Shah (DIN 08627198); Mansi Shah (DIN 09220482).
Where is Ideawise Technologies Private Limited registered?
The registered office of Ideawise Technologies Private Limited is at H.No-60-KH No-115, Vijay Vihar, Uttam Nagar, Block N, West Delhi, New Delhi, Delhi - 110059 (consistent across Tofler, TheCompanyCheck, InstaFinancials).
Information compiled from public registry and secondary sources (as of 2026-07-29). It may be incomplete or dated; verify independently before relying on it. Known gaps: Exact reconciled paid-up capital; verified director DINs from a second registry source; full standalone/consolidated P&L (revenue/EBITDA/PAT/net worth/borrowings) beyond FY25 top-line and ratios; shareholding cap table/percentages; any credit rating (likely genuinely absent given company scale); Indian Kanoon litigation records (likely genuinely none); confirmed multi-state GST footprint (only 1 GSTIN found).